RESMED INC (RMD) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:RMD - US7611521078 - Common Stock
RMD Key Statistics, Chart & Performance
The current stock price of RMD is 248.67 USD. In the past month the price decreased by -2.45%. In the past year, price increased by 4.94%.
RMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.72 | 223.17B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.45 | 208.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.89 | 143.84B | ||
| SYK | STRYKER CORP | 27.41 | 138.06B | ||
| BDX | BECTON DICKINSON AND CO | 14.12 | 58.10B | ||
| IDXX | IDEXX LABORATORIES INC | 55.27 | 55.66B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.47 | 49.92B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.89 | 39.49B | ||
| DXCM | DEXCOM INC | 37.46 | 27.18B | ||
| PODD | INSULET CORP | 63.72 | 20.48B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.65 | 18.68B | ||
| HOLX | HOLOGIC INC | 17.54 | 16.70B |
Related stock screener links
About RMD
Company Profile
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Company Info
RESMED INC
9001 Spectrum Center Blvd
San Diego CALIFORNIA 92123 US
CEO: MichaelJ.Farrell
Employees: 10600
Phone: 18587462400
RESMED INC / RMD FAQ
What does RESMED INC do?
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Can you provide the latest stock price for RESMED INC?
The current stock price of RMD is 248.67 USD. The price increased by 1.35% in the last trading session.
Does RMD stock pay dividends?
RESMED INC (RMD) has a dividend yield of 1%. The yearly dividend amount is currently 2.12.
What is the ChartMill rating of RESMED INC stock?
RMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is the analyst forecast for RMD stock?
25 analysts have analysed RMD and the average price target is 298.42 USD. This implies a price increase of 20% is expected in the next year compared to the current price of 248.67.
How many employees does RESMED INC have?
RESMED INC (RMD) currently has 10600 employees.
When does RESMED INC (RMD) report earnings?
RESMED INC (RMD) will report earnings on 2026-01-22.
RMD Technical Analysis
RMD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to RMD. Both the health and profitability get an excellent rating, making RMD a very profitable company, without any liquidiy or solvency issues.
RMD Financial Highlights
Over the last trailing twelve months RMD reported a non-GAAP Earnings per Share(EPS) of 9.9. The EPS increased by 19.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 27.35% | ||
| ROA | 17.31% | ||
| ROE | 23.49% | ||
| Debt/Equity | 0.07 |
RMD Forecast & Estimates
25 analysts have analysed RMD and the average price target is 298.42 USD. This implies a price increase of 20% is expected in the next year compared to the current price of 248.67.
For the next year, analysts expect an EPS growth of 15% and a revenue growth 9.24% for RMD